BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26950553)

  • 1. A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers.
    Kim A; Lim KS; Lee H; Chung H; Yoon SH; Yu KS; Cho JY; Jang IJ; Chung JY
    Int Clin Psychopharmacol; 2016 Jul; 31(4):210-7. PubMed ID: 26950553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loxapine delivered as a thermally generated aerosol does not prolong QTc in a thorough QT/QTc study in healthy subjects.
    Spyker DA; Voloshko P; Heyman ER; Cassella JV
    J Clin Pharmacol; 2014 Jun; 54(6):665-74. PubMed ID: 24375070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.
    de Kam PJ; van Kuijk J; Prohn M; Thomsen T; Peeters P
    Clin Drug Investig; 2010; 30(9):599-611. PubMed ID: 20568829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Celecoxib on the QTc Interval: A Thorough QT/QTc Study.
    Kim S; Lee H; Ko JW; Kim JR
    Clin Ther; 2019 Nov; 41(11):2204-2218. PubMed ID: 31564512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lomitapide at supratherapeutic plasma levels does not prolong the Qtc interval--results from a TQT study with moxifloxacin and ketoconazole.
    Darpo B; Ferber G; Zhou M; Sumeray M; Sager P
    Ann Noninvasive Electrocardiol; 2013 Nov; 18(6):577-89. PubMed ID: 24118671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to Evaluating QT Prolongation of Quetiapine Fumarate in Late Stage of Clinical Development Using Concentration-QTc Modeling and Simulation in Japanese Patients With Bipolar Disorder.
    Fukushi R; Nomura Y; Katashima M; Komatsu K; Sato Y; Takada A
    Clin Ther; 2020 Aug; 42(8):1483-1493.e1. PubMed ID: 32792252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
    de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P
    Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipragliflozin does not prolong QTc interval in healthy male and female subjects: a phase I study.
    Zhang W; Smulders R; Abeyratne A; Dietz A; Krauwinkel W; Kadokura T; Keirns J
    Clin Ther; 2013 Aug; 35(8):1150-1161.e3. PubMed ID: 23910665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study.
    Shen Z; Gillen M; Tieu K; Nguyen M; Harmon E; Wilson DM; Kerr B; Lee CA
    Drug Des Devel Ther; 2016; 10():3509-3517. PubMed ID: 27826183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers.
    Taubel J; Naseem A; Harada T; Wang D; Arezina R; Lorch U; Camm AJ
    Br J Clin Pharmacol; 2010 Apr; 69(4):391-400. PubMed ID: 20406223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
    Sun L; Yagoda S; Xue H; Brown R; Nangia N; McDonnell D; Rege B; von Moltke L; Darpo B
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109881. PubMed ID: 32004636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Eluxadoline Effect on Cardiac Repolarization.
    Bonifacio L; Hunt TL; McIntyre G; Dove LS; Covington PS
    Clin Pharmacol Drug Dev; 2018 Sep; 7(7):727-736. PubMed ID: 29659201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines.
    Donado E; Izquierdo I; Pérez I; García O; Antonijoan RM; Gich I; Solans A; Peña J; Morganroth J; Barbanoj MJ
    Br J Clin Pharmacol; 2010 Apr; 69(4):401-10. PubMed ID: 20406224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacosamide cardiac safety: a thorough QT/QTc trial in healthy volunteers.
    Kropeit D; Johnson M; Cawello W; Rudd GD; Horstmann R
    Acta Neurol Scand; 2015 Nov; 132(5):346-54. PubMed ID: 25932544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of moxifloxacin on QTc interval in healthy Korean male subjects.
    Moon SJ; Lee J; An H; Yim DS; Chung JY; Yu KS; Cho JY; Lim KS
    Drugs R D; 2014 Jun; 14(2):63-71. PubMed ID: 24691742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of relationship between plasma levels of escitalopram and QTc-interval length.
    Carceller-Sindreu M; de Diego-Adeliño J; Portella MJ; Garcia-Moll X; Figueras M; Fernandez-Vidal A; Queraltó JM; Puigdemont D; Álvarez E
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):815-822. PubMed ID: 28116499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.
    Khalilieh SG; Yee KL; Fan L; Liu R; Heber W; Dunzo E; Triantafyllou I; Hussaini A; Iwamoto M
    Clin Drug Investig; 2017 Oct; 37(10):975-984. PubMed ID: 28785879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials.
    Harris SC; Morganroth J; Ripa SR; Thorn MD; Colucci S
    Postgrad Med; 2017 Jan; 129(1):69-80. PubMed ID: 27927048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.
    van Gorp F; Duffull S; Hackett LP; Isbister GK
    Br J Clin Pharmacol; 2012 Mar; 73(3):402-10. PubMed ID: 21883384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial.
    Jensen KG; Gärtner S; Correll CU; Rudå D; Klauber DG; Stentebjerg-Olesen M; Fagerlund B; Jepsen JR; Fink-Jensen A; Juul K; Pagsberg AK
    Psychopharmacology (Berl); 2018 Mar; 235(3):681-693. PubMed ID: 29185022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.